多囊卵巢综合征中的高同型半胱氨酸血症:甜菜碱-同型半胱氨酸甲基转移酶和胱硫醚β-合酶介导的同型半胱氨酸代谢降低
研究检测非肥胖与肥胖对照组及多囊卵巢综合征(PCOS)患者血清同型半胱氨酸浓度,并在脱氢表雄酮(DHEA)或DHEA联合高脂饮食(HFD)诱导的PCOS大鼠模型中研究同型半胱氨酸代谢。结果发现肥胖组PCOS患者血清同型半胱氨酸高于对照(P<0.05),肥胖组无论是否PCOS均显著高于非肥胖组(均P<0.05);DHEA+HFD大鼠血清同型半胱氨酸显著升高(P<0.05),肝脏Bhmt和Cbs mRNA显著降低(均P<0.0001),Cbs和Bhmt启动子甲基化显著降低(P<0.05和P<0.0001)。结论提示肝脏Bhmt和Cbs介导的同型半胱氨酸代谢降低可能参与PCOS高同型半胱氨酸血症。
要点
- 肥胖组PCOS患者血清同型半胱氨酸高于肥胖对照组(P<0.05)。
- 肥胖组血清同型半胱氨酸显著高于非肥胖组,无论PCOS状态(均P<0.05)。
- DHEA+HFD大鼠肝脏Bhmt和Cbs mRNA显著降低(均P<0.0001),启动子甲基化降低。
核心结论
- 肝脏Bhmt和Cbs介导的同型半胱氨酸代谢降低可能参与PCOS高同型半胱氨酸血症。
- 研究为进一步证实肝脏功能降低在PCOS中的潜在作用提供了证据。
研究设计与样本
- 检测非肥胖和肥胖对照组及PCOS患者血清同型半胱氨酸浓度。
- 采用脱氢表雄酮(DHEA)或DHEA联合高脂饮食(HFD)建立PCOS大鼠模型研究同型半胱氨酸代谢。
主要发现
- 肥胖组PCOS患者血清同型半胱氨酸高于肥胖对照组(P<0.05)。
- 肥胖组血清同型半胱氨酸显著高于非肥胖组,无论PCOS状态(均P<0.05)。
- DHEA+HFD诱导大鼠血清同型半胱氨酸较对照显著升高(P<0.05)。
- DHEA+HFD大鼠肝脏Bhmt和Cbs mRNA较对照显著降低(均P<0.0001)。
- DHEA+HFD组Cbs启动子甲基化较对照显著降低(P<0.05),Bhmt启动子甲基化显著降低(P<0.05和P<0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What are the metabolic characteristics of homocysteine in polycystic ovary syndrome (PCOS)? DESIGN: Homocysteine concentrations were determined in serum samples from non-obese and obese control subjects and PCOS patients. Homocysteine metabolism was studied in a rat model of PCOS established using dehydroepiandrosterone (DHEA) or DHEA in combination with a high-fat diet (HFD). RESULTS: It was shown that (i) serum homocysteine concentrations were greater in PCOS patients than in control subjects in the obese group (P < 0.05) and serum homocysteine concentrations were significantly higher in the obese group than in the non-obese group, regardless of PCOS status (both P < 0.05); (ii) serum homocysteine concentrations were significantly increased in DHEA + HFD-induced rats compared with controls (P < 0.05); (iii) when compared with the control group, mRNA concentrations of homocysteine metabolic enzymes Bhmt and Cbs were significantly reduced in the liver tissues of DHEA + HFD-induced rats (both P < 0.0001); (iv) when compared with the control group, there was a significant decrease in the methylation concentrations of the Cbs (P < 0.05) and Bhmt (P < 0.05 and P < 0.0001) promoter in the DHEA + HFD group. The methylation patterns, together with previous data, indicate that hypomethylated promoter-mediated transcriptional activation of Bhmt and Cbs might be a defence mechanism against PCOS-related hyperhomocysteinemia. CONCLUSIONS: These findings indicate that decreased liver Bhmt and Cbs-mediated homocysteine metabolism might have a role in hyperhomocysteinemia in PCOS and provides further evidence for a potential role of decreased liver function in PCOS.
引用
- Li D, Liu HX, Fang YY, et al. Hyperhomocysteinemia in polycystic ovary syndrome: decreased betaine-homocysteine methyltransferase and cystathionine β-synthase-mediated homocysteine metabolism. Reprod Biomed Online. 2018. PMID: 29804940. doi:10.1016/j.rbmo.2018.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。